Chad Gassert - 11 Mar 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Chad Gassert, by attorney-in-fact Stephen P. Carey
Issuer symbol
ANIP
Transactions as of
11 Mar 2024
Transactions value $
-$1,316,200
Form type
4
Filing time
13 Mar 2024, 16:44:44 UTC
Previous filing
01 Mar 2024
Next filing
02 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$1.32M -20K -6.82% $65.81 273K 11 Mar 2024 Held by Chali Properties LLC F1, F2, F3
holding ANIP Common Stock 49.7K 11 Mar 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023.
F2 The shares were sold in multiple trades at prices ranging from $65.23 to $66.34. The price reported above reflects the weighted average sales price.
F3 The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.